T1	Participants 178 256	children with autistic disorder and related pervasive developmental disorders,
T2	Participants 425 477	pervasive developmental disorders and hyperactivity.
T3	Participants 627 765	Seventy-two drug-free children, aged 5 to 14 years, with pervasive developmental disorders accompanied by moderate to severe hyperactivity
T4	Participants 1155 1200	Subjects who tolerated the test dose (n = 66)
T5	Participants 2238 2301	hyperactivity associated with pervasive developmental disorders
